COLLEGE PARK, Md., July 30 The University of Maryland issued the following news release:A student-run company that helps doctors submit prescriptions online, as new federal regulations will eventually require, has made a University of Maryland senior a finalist for Entrepreneur Magazine’s Entrepreneur of 2010 Awards.Greg Waldstreicher, a student in the Hinman CEOs Program – [...]
COLLEGE PARK, Md., July 28 /PRNewswire-USNewswire/ Greg Waldstreicher, a senior in the Maryland Technology Enterprise Institute (Mtech) Hinman CEOs Program, is one of five finalists for Entrepreneur Magazine’s Entrepreneur of 2010 Awards in the College Entrepreneur category.The overall 2010 winner will be selected by voters on the Entrepreneur Magazine website. Voting ends September 10.Waldstreicher [...]
To: BUSINESS, AND EDUCATION EDITORSContact: Eric Schurr of the University of Maryland, +1-301-405-3889, schurr@umd.eduCOLLEGE PARK, Md., July 28 /PRNewswire-USNewswire/ GregWaldstreicher, a senior in the Maryland Technology EnterpriseInstitute (Mtech) Hinman CEOs Program, is one of five finalists forEntrepreneur Magazine’s Entrepreneur of 2010 Awards in the CollegeEntrepreneur category.The overall 2010 winner will be selected by [...]
SILVER SPRING, Md., July 28 /PRNewswire-USNewswire/ The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.(Logo: (Logo: Drooling is normal in infants. But a significant proportion of the developmentally disabled population experiences drooling caused primarily by [...]
To: HEALTH, MEDICAL, AND NATIONAL EDITORSContact: Elaine Gansz Bobo of the U.S. Food and Drug Administration, +1-301-796-7567, elaine.bobo@fda.hhs.gov, Consumer Inquiries: 888-INFO-FDASILVER SPRING, Md., July 28 /PRNewswire-USNewswire/ The U.S. Foodand Drug Administration today approved Cuvposa (glycopyrrolate) OralSolution to treat chronic severe drooling caused by neurologicdisorders in children ages 3 years to 16 years.(Logo: is [...]
BOWIE, Md., July 28 /PRNewswire/ MedAssurant Inc., a leading provider of data-driven healthcare solutions, announced that research from a major study by America's Health Insurance Plans (AHIP) was presented in Washington D.C. today featuring MedAssurant's data and analytics. The results were presented by AHIP alongside executives from Aetna, Humana, Tufts and United in a [...]
COLLEGE PARK, Md., July 28 /PRNewswire-USNewswire/ Greg Waldstreicher, a senior in the Maryland Technology Enterprise Institute (Mtech) Hinman CEOs Program, is one of five finalists for Entrepreneur Magazine's Entrepreneur of 2010 Awards in the College Entrepreneur category.The overall 2010 winner will be selected by voters on the Entrepreneur Magazine website. Voting ends September 10.Waldstreicher [...]
Bethesda, Md. (NNS) Patients receiving chemotherapy treatments at the National Naval Medical Center (NNMC) have found that laughing and sharing common experiences help heal.Staff and patients decided recently to add a little twist to the healing process to lighten the mood with dressing up and providing food and games to a small group of [...]
SILVER SPRING, Md., July 23 /PRNewswire-USNewswire/ The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis (DVT), a potentially deadly blood clotting condition.(Logo: for use in 1993, Lovenox is made from heparin, a blood-thinning drug whose active ingredient [...]
UPDATED: FDA Approves First Generic Enoxaparin Sodium InjectionNOTE TO EDITORS: In response to multiple questions about the product’s indications, the press release was revised to clarify that Sandoz’s enoxaparin soldium for injection was approved for all of the same indications as Lovenox.SILVER SPRING, Md., July 23 /PRNewswire-USNewswire/ The U.S. Food and Drug Administration today [...]
